Pregnancy Trimester, Second
"Pregnancy Trimester, Second" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation.
Descriptor ID |
D011262
|
MeSH Number(s) |
G08.686.707.490
|
Concept/Terms |
Pregnancy Trimester, Second- Pregnancy Trimester, Second
- Pregnancy Trimesters, Second
- Second Pregnancy Trimester
- Second Pregnancy Trimesters
- Pregnancy, Second Trimester
- Pregnancies, Second Trimester
- Second Trimester Pregnancies
- Second Trimester Pregnancy
- Trimester, Second
- Second Trimester
- Second Trimesters
- Trimesters, Second
- Midtrimester
- Midtrimesters
|
Below are MeSH descriptors whose meaning is more general than "Pregnancy Trimester, Second".
Below are MeSH descriptors whose meaning is more specific than "Pregnancy Trimester, Second".
This graph shows the total number of publications written about "Pregnancy Trimester, Second" by people in this website by year, and whether "Pregnancy Trimester, Second" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2015 | 0 | 1 | 1 |
2016 | 1 | 1 | 2 |
2017 | 7 | 17 | 24 |
2018 | 4 | 14 | 18 |
2019 | 2 | 6 | 8 |
2020 | 0 | 6 | 6 |
2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pregnancy Trimester, Second" by people in Profiles.
-
Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study. Contraception. 2022 03; 107:23-28.
-
Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199. Viruses. 2021 08 05; 13(8).
-
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199". Viruses. 2021 08 05; 13(8).
-
Disruptions to Abortion Care in Louisiana During Early Months of the COVID-19 Pandemic. Am J Public Health. 2021 08; 111(8):1504-1512.
-
SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave. BMC Pregnancy Childbirth. 2021 Apr 26; 21(1):326.
-
The association between COVID-19 pandemic and maternal isolated hypothyroxinemia in first and second trimesters. Psychoneuroendocrinology. 2021 06; 128:105210.
-
Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology. Viruses. 2021 03 10; 13(3).
-
Effect of SARS-CoV-2 infection during the second half of pregnancy on fetal growth and hemodynamics: A prospective study. Acta Obstet Gynecol Scand. 2021 06; 100(6):1034-1039.
-
Severe coronavirus disease pneumonia in a pregnant woman at 25 weeks' gestation: A case report. J Obstet Gynaecol Res. 2021 Apr; 47(4):1583-1588.
-
Investigating the risk of maternal-fetal transmission of SARS-CoV-2 in early pregnancy. Placenta. 2021 03; 106:25-29.